Search

Search Constraints

You searched for: Author/Creator Orsucci, Lorella

Search Results

1. A phase II study of bendamustine in combination with rituximab as initial treatment for patients with indolent non-follicular non-Hodgkin lymphoma. Issue 4 (2nd April 2016)

2. Bendamustine and rituximab combination is safe and effective as salvage regimen in Waldenström macroglobulinemia. Issue 9 (2nd September 2015)

4. Chlorambucil plus rituximab with or without maintenance rituximab as first‐line treatment for elderly chronic lymphocytic leukemia patients. Issue 5 (18th February 2014)

5. Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials. (June 2016)

6. Efficacy of rituximab in anti‐myelin‐associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow‐up. (25th September 2022)

7. How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia. Issue 8 (3rd July 2022)

8. Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B‐cell lymphoma of the central nervous system – an international study of feasibility and efficacy in routine clinical practice. (29th January 2020)

9. Management of chronic lymphocytic leukemia in Italy during a one year of the COVID‐19 pandemic and at the start of the vaccination program. A Campus CLL report. Issue 4 (13th July 2021)

10. Role of chemotherapy in the treatment of chronic lymphocytic leukemia in the era of targeted therapies in Italy. A Campus CLL network report. Issue 1 (19th August 2022)